GlassScriptPhysician profile
Melissa Duperval
NPI 1588974729
$839.89
in general payments reported to CMS, 2019-2025
12 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.38 · 2020: $157 · 2021: $65.35 · 2022: $57.78 · 2023: $178 · 2024: $130 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $183.39 | 2019-2025 | Slynd |
| Organon LLC | $131.35 | 2021-2025 | Nexplanon |
| Abbvie INC. | $129.07 | 2021-2025 | Liletta |
| Avion Pharmaceuticals | $119.41 | 2020-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $93.55 | 2022-2025 | |
| Pfizer INC. | $57.93 | 2023-2025 | |
| Millicent US INC | $45.27 | 2025 | Femlyv |
| Evofem Biosciences, INC. | $22.91 | 2024 | |
| Lupin INC. | $16.39 | 2020 | |
| Coopersurgical, INC. | $14.65 | 2025 | |
| Allergan, INC. | $14.41 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Duperval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.